Power to the Patients
Brandon Li
En yeni bölüm
Why Enveda Teaches AI to Read Nature's Chemistry
Why Enveda Teaches AI to Read Nature's Chemistry
Bu podcast hakkında
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation.
Looking for a clinical trial? Visit us at www.withpower.com
Bölümler
58 bölümden en yeni 20 bölüm
- Why Enveda Teaches AI to Read Nature's Chemistry · 41 dk · Bölüm 32Isn’t it crazy to think that half of FDA-approved small molecule drugs have roots in nature? But José Trevejo, Chief Medical Officer at Enveda, says the opportunity now is not to…
- Reversing Chemo failure in ovarian cancer with Thomas Zindrick · 38 dk · Bölüm 31Platinum chemotherapy is the backbone of ovarian cancer treatment. But for far too many patients, it eventually stops working. In this episode of Power to the Patients, Brandon…
- The Gout Narrative Keeping Patients Sick and What Crystalys Therapeutics Is Doing Differently · 36 dk · Bölüm 30Most people still think gout is a lifestyle condition caused primarily by diet. But this belief is a big reason patients have been underserved for decades. In this episode of…
- Developing a treatment for Alzheimer's in the world of AI with Sacha Schermerhorn · 34 dk · Bölüm 29Learn about clinical trial design for small molecule therapies using biomarkers in Alzheimer's research and AI in drug development. Brandon Li talks with Sacha Schermerhorn…
- How Neuroplasticity Is Shaping the Next Generation of Psychiatric Medicines · 34 dk · Bölüm 28Dr. Aaron Koenig, Chief Medical Officer at Delix Therapeutics, sheds light on a new class of medicines designed to promote neuroplasticity without the hallucinogenic effects…
- 70% Remission for Postpartum Depression? The Psychedelic Breakthrough · 36 dk · Bölüm 27Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how…
- Why Psychiatry Is Finally Breaking Free From Dopamine · 29 dk · Bölüm 26In this episode of Power to the Patients, host Brandon Li sits down with Ken Kramer, PhD, Vice President and Head of Neuropsychiatry Medical Affairs at Bristol Myers Squibb, to…
- Precision Medicine Got Kidney Disease Wrong—Until Now · 42 dk · Bölüm 25Explore how variant functionalization is driving the future of mechanism-driven medicines as host Brandon interviews Jason Coloma, CEO of Maze Therapeutics, on Power to the…
- Why Dr. Ken Sharlin Believes Most Neurological Diseases Are Reversible · 38 dk · Bölüm 24In this episode of Power to the Patients, host Brandon Li sits down with Dr. Ken Sharlin, neurologist, researcher, and clinical trial investigator, to explore how precision…
- Why Serotonin Isn’t Outdated, Our Thinking Is · 41 dk · Bölüm 23In this episode of Power to the Patients, host Brandon Li sits down with Dr. Jacob Jacobsen, neuroscientist and CEO of Evecxia Therapeutics, to challenge some of psychiatry’s…
- Who Really Protects Patients in Clinical Trials? With Dr. Lara Shirikjian · 40 dk · Bölüm 22In this episode of Power to the Patients, host Brandon Li sits down with Dr. Lara Shirikjian, Medical Director at CenExel, to explore why operational excellence, not just…
- Turning Pain Into Progress: How Sonia Prashar Built a Mission Around Mental Health · 34 dk · Bölüm 21In this episode of Power to the Patients, Brandon Li and Sonia Prashar, Founder and CEO of AIM Trials, sit down to discuss how hybrid and decentralized clinical trial models are…
- The Synapse Secret: How One Molecule Normalized Brain Activity in Fragile X Patients · 39 dk · Bölüm 20In this episode of Power to the Patients, Brandon Li sits down with Dr. Craig Erickson, Research Director and Research Endowed Professor at Cincinnati Children’s and Chief…
- Beyond Dopamine: Why Traditional Schizophrenia Treatments Miss 50% of Patient Needs · 32 dk · Bölüm 19In this episode of Power to the Patients, Brandon Li sits down with Dr. Laxminarayan Bhat, Founder and CEO of Reviva Pharmaceuticals, to explore groundbreaking developments in…
- The 20-Year Industry Secret: Redefining Neurodegenerative Treatment · 53 dk · Bölüm 18In this episode of Power to the Patients, Brandon Li sits down with Dr. Gabriel Vargas, Chief Medical Officer at CuraSen Therapeutics, to explore how targeting the adrenergic…
- One Mechanism, Three Conditions: A New Direction in Neurological Treatment · 35 dk · Bölüm 17What if inflammation was the key to unlocking treatments for Alzheimer's, Parkinson's, and Long COVID? In this episode of Power to the Patients, Brandon Li sits down with Cuong…
- Why Traditional Psychedelics Miss 90% of Neurology Patients - And The Solution · 42 dk · Bölüm 16In this episode of Power to the Patients, Brandon Li sits down with Dr. Chris Witowski, CEO and Co-Founder of Psilera, to explore the fascinating intersection of psychedelics and…
- Inside the ALS Breakthrough: 20-Year Journey to FDA Approval with Dr. Joseph Palumbo · 40 dk · Bölüm 15In this episode of Power to the Patients, Brandon Li and Dr. Palumbo, Chief Medical Officer at BioVie Pharma, explore the evolving landscape of neuroscience research, the…
- Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan · 41 dk · Bölüm 14What if you could learn the secrets behind one of psychiatry's most significant breakthroughs in decades? In this episode of Power to the Patients, host Brandon Li sits down with…
- Dr. Anantha Shekhar on the Convergence of Psychiatry, Neurology, and the Next Era of Brain Medicine · 50 dk · Bölüm 13In this episode of Power to the Patients, Brandon Li speaks with Dr. Anantha Shekhar, Senior Vice Chancellor for Health Sciences and Dean of the School of Medicine at the…
